Cannabix Technologies Inc (BLOZF)

[Money $hot]

So Cannabix Is An MJ Play Eh? OK

Excerpt:

How the biggest pot stocks plan to win in what is about to become a 'brutal' industry

The cannabis hype is about to come face-to-face with reality.

After Canada legalizes recreational marijuana on Oct. 17, it will only take a quarter or two for clear winners and losers to emerge, according to investors and analysts who follow the sector. This means investors will have to get choosier as the days of highly correlated stock moves draw to a close.

“These have all been concept stocks and they’re going to actually have to be real companies in another few months, which I think a lot of guys are terrified about,” said Greg Taylor, who manages the Purpose Marijuana Opportunities Fund. Taylor prefers CannTrust Holdings Inc., Hexo Corp. and Organigram Holdings Inc., which he says trade at a “more realistic valuation” than some of their bigger peers.

“I get asked all the time, is there going to be consolidation? I think there’s going to be disintegration,” Bruce Linton, chief executive officer of Canopy Growth Corp., told a Toronto marijuana conference in August. “Disintegration will happen when people make promises at valuations they can’t possibly meet.”

Few Players

There may only be half a dozen major players left three years after legalization, said Eric Paul, chairman of Vaughan, Ontario-based CannTrust.

The rest “are going to be bankrupt or out of business because their business models don’t work,” Paul said. “This industry is far more brutal than most people understand.”

So what will distinguish winners from losers? A meaningful presence in Canada’s recreational market combined with exposure to the international medical market is one key factor, according to Matt Bottomley, analyst at Canaccord Genuity Group Inc. Aphria Inc., CannTrust and Hexo are some of Bottomley’s top picks.

“I think five years from now you’re going to see the international medical market come from what is probably US$1 billion or maybe less today to probably US$50 billion or US$100 billion,” Bottomley said.

https://www.thegrowthop.com/cannabis/as-cannabis-d-day-approaches-winners-and-losers-set-to-emerge/wcm/0472243f-7c56-434a-ad68-bd01a098273c

Matt Bottomley's analysis may bode well for MJ Pharmaceutical companies.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144264164

Just a thought,

/////AMG